ghk-cu copper overload risk wilson's disease Frontiers Copper and liver fibrosis in
Description
Clinical trials exploring its therapeutic efficacy in human diseases offer exciting prospects for the future
The cell evidence establishes biological plausibility, not clinical proof
Peptidsequenzen, die von Knorpel-ECM-Proteinen oder Wachstumsfaktoren abgeleitet sind (z
doi:10.1186/s12263-018-0591-9
